Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10945031 | 1.00 | TSHR (0.47) | TSHRTHRBDNM1HSD17B10CES2 | |
| SCHEMBL10941688 | 1.00 | TSHR (0.47) | TSHRTHRBDNM1HSD17B10CES2 | |
| SCHEMBL3380906 | 1.00 | — | — | |
| SCHEMBL3379274 | 1.00 | TSHR (0.47) | TSHRTHRBDNM1HSD17B10CES2 | |
| SCHEMBL11847801 | 1.00 | TSHR (0.47) | TSHRTHRBDNM1HSD17B10CES2 | |
| SCHEMBL10949053 | 1.00 | TSHR (0.47) | TSHRTHRBDNM1HSD17B10CES2 | |
| SCHEMBL31244850 | 1.00 | TSHR (0.47) | TSHRTHRBDNM1HSD17B10CES2 | |
| SCHEMBL31651405 | 1.00 | TSHR (0.47) | TSHRTHRBDNM1HSD17B10CES2 | |
| SCHEMBL3379235 | 0.97 | — | — | |
| SCHEMBL575853 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250219129-A1 | SOLID-STATE ELECTROLYTE SYNTHESIS USING A SULFUR-CONTAINING ADDITIVE | Solid Power Operating, Inc. | 2025-07-03 | — | — | US | claimed |
| US-20250219129-A1 | SOLID-STATE ELECTROLYTE SYNTHESIS USING A SULFUR-CONTAINING ADDITIVE | Solid Power Operating, Inc. | 2025-07-03 | — | — | US | disclosed |
| EP-2164992-B1 | COMPOSITIONS AND METHODS FOR BINDING LYSOPHOSPHATIDIC ACID | LPATH INC (US) | 2016-05-04 | — | — | EP | disclosed |
| US-20140199293-A1 | HUMANIZED ANTIBODY COMPOSITIONS AND METHODS FOR BINDING LYSOPHOSPHATIDIC ACID | APOLLO ENDOSURGERY, INC. | 2014-07-17 | — | — | US | disclosed |
| US-7915810-B2 | Display device, and method for repairing a defective pixel | FUJIFILM CORPORATION (JP) | 2011-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140199293-A1 | HUMANIZED ANTIBODY COMPOSITIONS AND METHODS FOR BINDING LYSOPHOSPHATIDIC ACID | LPAR5, LPAR2, LPAR6 | TSHR 2239/4885THRB 2844/4885DNM1 1017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.